Rheumatoid Arthritis Market Analysis
The global rheumatoid arthritis market is likely to grow at an admirable CAGR between 2016- 2022, according to the new report by Market Research Future (MRFR). Rheumatoid arthritis or RA, simply put, is a chronic auto-immune disorder that mostly affects joints along with the extra-articular organs and articular tissues. It is often progressive and causes swelling of joints, stiffness, and pain. Biologic agents, disease-modifying anti-rheumatic drug type (DMARDs), steroids, and non-steroidal anti-inflammatory drug type (NSAID) are the different types of drugs to treat rheumatoid arthritis. Total joint replacement, tendor repair, and synovectomy are the different types of rheumatoid arthritis treatments.
FREE SAMPLE COPY OF “Rheumatoid arthritis Market Research Report- Global forecast till 2023”@ https://www.marketresearchfuture.com/sample_request/1658
Various factors are propelling the global rheumatoid arthritis market growth. According to the new MRFR report, such factors include favorable reimbursement policies, presence of high-cost drugs, growing geriatric population, the growing awareness about arthritis as well as its prevention among healthcare professionals and patients, and improvements in healthcare infrastructure & diagnostics. Additional factors adding market growth include developments in novel biologics and biosimilars.
On the contrary, higher biologics & biosimilars cost, coupled with side effects from the medication are factors that may limit the global rheumatoid arthritis market growth over the forecast period. Besides, the grave effect of the recent COVID-19 pandemic has also impacted the market growth to some extent.
Rheumatoid Arthritis Market Segmentation
The MRFR report gives an inclusive segmental analysis of the global rheumatoid arthritis market report based on drug type, diagnosis, and treatment.
By drug type, the global rheumatoid arthritis market is segmented into biologic agents, disease-modifying anti-rheumatic drug type (DMARDs), steroids, and non-steroidal anti-inflammatory drug type (NSAID). Of these, the biologic agents will lead the market over the forecast period.
By treatment, the global rheumatoid arthritis market is segmented into total joint replacement, tendor repair, and synovectomy.
By diagnosis, the global rheumatoid arthritis market is segmented into synovial fluid analysis, ESR (erythrocyte sedimentation rate) test, CCP, and C-reactive protein (CRP) test.
Rheumatoid Arthritis Market Regional Analysis
Based on the region, the global rheumatoid arthritis market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific (APAC), & the Middle East and Africa (MEA). Of these, the Americas will lead the market over the forecast period. Favorable initiatives by the government for research and development, coupled with the rising patient pool consulting professionals for rheumatoid arthritis, are adding to the global rheumatoid arthritis growth in the region. Besides, increasing awareness about rheumatoid arthritis and huge investments to improve the region’s medical facilities and healthcare are also adding market growth.
The global rheumatoid arthritis market in Europe is predicted to have the second-largest share over the forecast period. Rising prevalence of rheumatoid arthritis in the UK and favorable initiatives undertaken by the government to create awareness are adding to the global rheumatoid arthritis market growth in the region. The UK has the maximum share in the region.
The global rheumatoid arthritis market in the APAC region is predicted to grow at a fast pace over the forecast period. Various developments in the region to treat rheumatoid arthritis, expansion of medical and healthcare infrastructure, and entry of new drugs are adding to the global rheumatoid arthritis market growth in the region.
The global rheumatoid arthritis market in the MEA is predicted to have the smallest share over the forecast period for poor medical facilities, less emphasis on R&D activities, and lack of awareness.
Rheumatoid Arthritis Market Key Players
Leading players profiled in the global rheumatoid arthritis market report include AstraZeneca (U.K), Sanofi (France), Vertex Pharmaceuticals Incorporated (U.S), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Bristol-Myers Squibb Company (U.S), Eli Lilly & Company (U.S), and Pfizer Inc (U.S), among others.
OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/rheumatoid-arthritis-market-1658
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
